Two InfuSystem infusion pumps added by CMS to NOPAIN Act payment list

InfuSystem (INFU) announced that the Centers for Medicare and Medicaid Services has added two of the electronic infusion pumps currently utilized by the company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027 when provided with a covered surgical procedure. This payment may now be available to InfuSystem’s current and potential Pain Management customers for certain patients. This initiative is part of a broader strategy by CMS to combat the opioid crisis by promoting safer pain management alternatives. The two pumps are the CADD-Solis manufactured by ICU Medical, and Eitan Medical’s Sapphire pump.